Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 650

1.

Is the benefit of oxaliplatin in rectal cancer clinically relevant?

Glimelius B.

Lancet Oncol. 2015 Jul 15. pii: S1470-2045(15)00018-2. doi: 10.1016/S1470-2045(15)00018-2. [Epub ahead of print] No abstract available.

PMID:
26189066
2.

Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial.

Sclafani F, Chau I, Cunningham D, Peckitt C, Lampis A, Hahne JC, Braconi C, Tabernero J, Glimelius B, Cervantes A, Begum R, Gonzalez De Castro D, Hulkki Wilson S, Eltahir Z, Wotherspoon A, Tait D, Brown G, Oates J, Valeri N.

Ann Oncol. 2015 Jul 10. pii: mdv285. [Epub ahead of print]

PMID:
26162609
3.

Time trends, improvements and national auditing of rectal cancer management over an 18-year period.

Kodeda K, Johansson R, Zar N, Birgisson H, Dahlberg M, Skullman S, Lindmark G, Glimelius B, Påhlman L, Martling A.

Colorectal Dis. 2015 Jul 8. doi: 10.1111/codi.13060. [Epub ahead of print]

PMID:
26155848
4.

High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort.

Sorbye H, Dragomir A, Sundström M, Pfeiffer P, Thunberg U, Bergfors M, Aasebø K, Eide GE, Ponten F, Qvortrup C, Glimelius B.

PLoS One. 2015 Jun 29;10(6):e0131046. doi: 10.1371/journal.pone.0131046. eCollection 2015.

5.

Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer.

Pettersson D, Lörinc E, Holm T, Iversen H, Cedermark B, Glimelius B, Martling A.

Br J Surg. 2015 Jul;102(8):972-8. doi: 10.1002/bjs.9811.

PMID:
26095256
6.

The water-perfusable tissue fraction of colorectal cancer metastases is increased by the selective PDGF-receptor inhibitor imatinib but not the IL-1 receptor antagonist anakinra, a study using serial dynamic 15O-water PET.

Lubberink M, Golla SS, Jonasson M, Rubin K, Glimelius B, Sörensen J, Nygren P.

J Nucl Med. 2015 Jun 11. pii: jnumed.114.151894. [Epub ahead of print]

PMID:
26069310
7.

Short- and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Intensified Neoadjuvant Strategy in the Randomized Phase 2 EXPERT-C Trial.

Sclafani F, Peckitt C, Cunningham D, Tait D, Giralt J, Glimelius B, Keränen SR, Bateman A, Hickish T, Tabernero J, Thomas J, Brown G, Oates J, Chau I.

Int J Radiat Oncol Biol Phys. 2015 Apr 4. pii: S0360-3016(15)00371-5. doi: 10.1016/j.ijrobp.2015.03.038. [Epub ahead of print]

PMID:
26031368
8.

Identification of Distress in Oncology Patients: A Comparison of the Hospital Anxiety and Depression Scale and a Thorough Clinical Assessment.

Thalén-Lindström AM, Glimelius BG, Johansson BB.

Cancer Nurs. 2015 May 26. [Epub ahead of print]

PMID:
26018818
9.

The evolution of radiotherapy techniques in the management of prostate cancer.

Høyer M, Muren LP, Glimelius B.

Acta Oncol. 2015 Jun;54(6):821-4. doi: 10.3109/0284186X.2015.1048555. No abstract available.

PMID:
25973556
10.

Maintenance Therapy With Cetuximab Every Second Week in the First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-7.5 Study by the Nordic Colorectal Cancer Biomodulation Group.

Pfeiffer P, Sorbye H, Qvortrup C, Karlberg M, Kersten C, Vistisen K, Lindh B, Bjerregaard JK, Glimelius B.

Clin Colorectal Cancer. 2015 Mar 25. pii: S1533-0028(15)00038-9. doi: 10.1016/j.clcc.2015.03.002. [Epub ahead of print]

PMID:
25956187
11.

Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery ± a fluoropyrimidine and surgery + a fluoropyrimidine ± oxaliplatin.

Bujko K, Glimelius B, Valentini V, Michalski W, Spalek M.

Eur J Surg Oncol. 2015 Jun;41(6):713-23. doi: 10.1016/j.ejso.2015.03.233. Epub 2015 Apr 13. Review.

PMID:
25911110
12.

Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer.

Birgisson H, Edlund K, Wallin U, Påhlman L, Kultima HG, Mayrhofer M, Micke P, Isaksson A, Botling J, Glimelius B, Sundström M.

BMC Cancer. 2015 Mar 14;15:125. doi: 10.1186/s12885-015-1144-x.

13.

Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved?

Glimelius B.

Acta Oncol. 2015 Apr;54(4):433-6. doi: 10.3109/0284186X.2015.1024331. Epub 2015 Mar 18. No abstract available.

PMID:
25783749
14.

Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab.

Tarpgaard LS, Christensen IJ, Høyer-Hansen G, Lund IK, Guren TK, Glimelius B, Sorbye H, Tveit KM, Nielsen HJ, Moreira JM, Pfeiffer P, Brünner N.

Int J Cancer. 2015 Feb 9. doi: 10.1002/ijc.29476. [Epub ahead of print]

PMID:
25664394
15.

A genome-wide association study of marginal zone lymphoma shows association to the HLA region.

Vijai J, Wang Z, Berndt SI, Skibola CF, Slager SL, de Sanjose S, Melbye M, Glimelius B, Bracci PM, Conde L, Birmann BM, Wang SS, Brooks-Wilson AR, Lan Q, de Bakker PI, Vermeulen RC, Portlock C, Ansell SM, Link BK, Riby J, North KE, Gu J, Hjalgrim H, Cozen W, Becker N, Teras LR, Spinelli JJ, Turner J, Zhang Y, Purdue MP, Giles GG, Kelly RS, Zeleniuch-Jacquotte A, Ennas MG, Monnereau A, Bertrand KA, Albanes D, Lightfoot T, Yeager M, Chung CC, Burdett L, Hutchinson A, Lawrence C, Montalvan R, Liang L, Huang J, Ma B, Villano DJ, Maria A, Corines M, Thomas T, Novak AJ, Dogan A, Liebow M, Thompson CA, Witzig TE, Habermann TM, Weiner GJ, Smith MT, Holly EA, Jackson RD, Tinker LF, Ye Y, Adami HO, Smedby KE, De Roos AJ, Hartge P, Morton LM, Severson RK, Benavente Y, Boffetta P, Brennan P, Foretova L, Maynadie M, McKay J, Staines A, Diver WR, Vajdic CM, Armstrong BK, Kricker A, Zheng T, Holford TR, Severi G, Vineis P, Ferri GM, Ricco R, Miligi L, Clavel J, Giovannucci E, Kraft P, Virtamo J, Smith A, Kane E, Roman E, Chiu BC, Fraumeni JF, Wu X, Cerhan JR, Offit K, Chanock SJ, Rothman N, Nieters A.

Nat Commun. 2015 Jan 8;6:5751. doi: 10.1038/ncomms6751.

16.

A template for writing radiotherapy protocols.

Nilsson P, Ceberg C, Kjellén E, Gagliardi G, Blomgren K, Nilsson S, Johansson M, Glimelius B.

Acta Oncol. 2015 Feb;54(2):275-9. doi: 10.3109/0284186X.2014.981285. Epub 2014 Dec 22.

PMID:
25529976
17.

Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines.

Leon O, Guren M, Hagberg O, Glimelius B, Dahl O, Havsteen H, Naucler G, Svensson C, Tveit KM, Jakobsen A, Pfeiffer P, Wanderås E, Ekman T, Lindh B, Balteskard L, Frykholm G, Johnsson A.

Radiother Oncol. 2014 Dec;113(3):352-8. doi: 10.1016/j.radonc.2014.10.002.

PMID:
25499203
18.

A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer.

Lindskog EB, Gunnarsdóttir KÁ, Derwinger K, Wettergren Y, Glimelius B, Kodeda K.

BMC Cancer. 2014 Dec 13;14:948. doi: 10.1186/1471-2407-14-948.

19.

Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.

Breugom AJ, van Gijn W, Muller EW, Berglund Å, van den Broek CB, Fokstuen T, Gelderblom H, Kapiteijn E, Leer JW, Marijnen CA, Martijn H, Meershoek-Klein Kranenbarg E, Nagtegaal ID, Påhlman L, Punt CJ, Putter H, Roodvoets AG, Rutten HJ, Steup WH, Glimelius B, van de Velde CJ; Cooperative Investigators of Dutch Colorectal Cancer Group and Nordic Gastrointestinal Tumour Adjuvant Therapy Group.

Ann Oncol. 2015 Apr;26(4):696-701. doi: 10.1093/annonc/mdu560. Epub 2014 Dec 5.

PMID:
25480874
20.

Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature.

Böckelman C, Engelmann BE, Kaprio T, Hansen TF, Glimelius B.

Acta Oncol. 2015 Jan;54(1):5-16. doi: 10.3109/0284186X.2014.975839. Epub 2014 Nov 28.

PMID:
25430983
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk